The cervical cancer vaccine, or HPV vaccine, is a vaccine given to prevent the development of cervical cancer. The occurrence of cervical cancer in women is inextricably linked to persistent infection with high-risk human papillomavirus types. HPV is divided into many types, most of which are not related to the occurrence of cervical cancer and are called low-risk types, but there are 14 types of HPV that cause the majority of cervical cancer and are called high-risk types. the main transmission route of HPV is sexual contact, followed by direct contact. HPV infection is more common in women, and if the infection is high-risk HPV, the body’s resistance has HPV infection is common among women, and if the infection is high-risk HPV, the body’s resistance has the ability to remove it, resulting in the persistence of high-risk HPV, which can easily induce cervical intraepithelial neoplasia or cervical cancer. Cervical cancer vaccination is a comprehensive and effective means to prevent cervical cancer, but even after receiving cervical cancer vaccination, cervical cytology examination should still be performed regularly because the cervical cancer vaccine targets the most common high-risk types, and there are also very few occurrences of cervical cancer unrelated to HPV infection. The incidence of cervical cancer is second only to breast cancer, and the incidence has been gradually increasing in recent years, and there is a trend of younger age, so cervical cancer vaccination is advocated in the right population.